

Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation. Among its major competitors, Cara Therapeutics is ranked in 11th place for NPS while Biogen is 1st, and Medivation is 2nd.Their current market cap is $1.08B